Altre lingue Genocea Biosciences, Inc.

Azioni

GNCAQ

US3724274010

Mercato chiuso - OTC Markets Altri mercati azionari 18:35:07 10/04/2024			Variaz. 5gg	Var. 1 gen.
0,000001 ^USD	0,00%		0,00%	0,00%

2023	Genocea Biosciences, Inc. ha cessato l'attività	CI
2023	Prima dichiarazione informativa modificata depositata da Genocea Biosciences, Inc.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Neoantigen-Based Personalized Cancer Therapeutic Vaccines Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023	30/11
Genocea Biosciences, Inc. Went Out of Business	19/05/23
Liquidation Plan Approved for Genocea Biosciences, Inc.	11/05/23
First Amended Disclosure Statement Filed by Genocea Biosciences, Inc.	21/03/23
Disclosure Statement Approved for Genocea Biosciences, Inc.	21/03/23
Joint Liquidation Plan and DIsclosure Statement Filed by Genocea Biosciences, Inc.	09/02/23
Motion for Asset Sale Approved for Genocea Biosciences, Inc.	21/09/22
Motion for Asset Sale Approved for Genocea Biosciences, Inc.	17/08/22
Bidding Procedure Approved for Genocea Biosciences, Inc.	09/08/22
Motion for Asset Sale Filed by Genocea Biosciences, Inc.	04/08/22
Genocea Biosciences, Inc. Filed for Bankruptcy	05/07/22
Genocea Biosciences, Inc.(NasdaqCM:GNCA) dropped from S&P TMI Index	07/06/22
Genocea Biosciences, Inc.(NasdaqCM:GNCA) dropped from NASDAQ Composite Index	02/06/22
GENOCEA BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	01/06/22
Genocea Biosciences, Inc. Announces Resignation of Ali Behbahani from Board of Director	01/06/22
24/7 Market News: Genocea Biosciences, Inc. (NASDAQ: GNCA) Dead Cat bouncing	25/05/22
US Futures Move Lower Ahead of Durable Goods, Investor Confidence Reports	25/05/22
Top Premarket Gainers	25/05/22
Genocea Biosciences To Wind Down Operations; Shares Fall	24/05/22
GENOCEA BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	24/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Genocea Biosciences, Inc.

Azioni

GNCAQ

US3724274010

Altre lingue

Filtri